Enovix (ENVX) Common Equity (2020 - 2026)

Enovix has reported Common Equity for 7 years, with the latest figure at $242.7 million in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 2.08% year-over-year to $242.7 million; the trailing twelve-month figure through Apr 2026 stood at $242.7 million (up 2.08% YoY), and the FY2025 full-year result was $274.0 million, up 9.87% from the prior year.
• Common Equity for Q2 2026 stood at $242.7 million, down from $274.0 million in the prior quarter.
• The five-year high for Common Equity was $428.7 million in Q3 2022, with the low at $170.2 million in Q3 2024.
• Historically, Common Equity has averaged $280.4 million across 5 years, with a median of $256.8 million in 2023.
• Annual changes were most pronounced in 2022 — Common Equity jumped 1300.2% — and 2023, when it plunged 42.32%.
• Enovix's Common Equity stood at $358.3 million in 2022, then decreased by 27.12% to $261.1 million in 2023, then fell by 4.48% to $249.4 million in 2024, then grew by 9.87% to $274.0 million in 2025, then decreased by 11.42% to $242.7 million in 2026.
• The last three Common Equity figures came in at $242.7 million (Q2 2026), $274.0 million (Q4 2025), and $297.1 million (Q3 2025), per Business Quant data.